JENKINS_HEALTH_CARE_LIMIT - Accounts


Company Registration No. 06873327 (England and Wales)
JENKINS HEALTH CARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019
JENKINS HEALTH CARE LIMITED
COMPANY INFORMATION
Directors
Mr B J Jenkins
Mrs M E Jenkins
Mr T S Jenkins
Company number
06873327
Registered office
Hollins Care Centre
The Hollins
Cimla
NEATH
UK
SA11 3BQ
Auditor
Baldwins Audit Services
Charter Court
Phoenix Way
Enterprise Park
SWANSEA
UK
SA7 9FS
JENKINS HEALTH CARE LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Group statement of comprehensive income
8
Group balance sheet
9
Company balance sheet
10
Group statement of changes in equity
11
Company statement of changes in equity
12
Group statement of cash flows
13
Notes to the financial statements
14 - 26
JENKINS HEALTH CARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2019
- 1 -

The directors present the strategic report for the year ended 31 March 2019.

Fair review of the business

The Group specialises in providing high quality, mental and social care to residents over the age of 65 in a safe and comfortable environment. The Group has care homes based in Neath and Swansea.

 

The most recent Care Inspectorate Wales ("CIW") reviews were carried out in January 2019 and October 2018 for the Group's care homes, the reports were wholly positive and are available to the public via the CIW website. The reports communicate there were no areas of non-compliance during the recent or previous inspections.

 

Average occupancy rates were marginally down during the year, however the impact on revenue was minimised by an increase in amounts receivable from local authorities per resident. The decrease in turnover has had an effect on operating profits, as the Group will continue to ensure high quality levels of catering, consumables and medicinal supplies are maintained for residents. A major impact on results during the year was due to increased payroll and agency costs. The Group experienced staffing issues during the period and to mitigate the risk of any deterioration in care, they sought to ensure they had sufficient staff available through utilising support agencies.

 

At the 31 March 2019, the Group acquired a further care home within it's South Wales region. The directors are confident the existing care homes in the Group together with this new addition will return the Group to a profit making position.

Key Performance Indicators
2019
2018
Variance
Avg. Occupany rate
81.9%
85.2%
Turnover
£3,281,364
£3,364,508
(£83,144)
Operating loss
£249,339
£18,626
£230,712
Future developments

The Group will continue to focus on sustained occupancy rates and improving profitability whilst also endeavoring to deliver high quality care and standards of service to ensure the best possible care and living environment can be provided to the residents.

Principal risks and uncertainties

The principal trading risks continue to be the uncertainty surrounding Brexit and it's potential impact to supplies and care workers, then budgetary constraints on local authorities. Local authorities have a continuing policy of providing care at home wherever possible resulting in reduced referrals for residential and nursing homes. The Group seek to mitigate risks by ensuring they maintain high levels of quality and resources to increase occupancy rates.

JENKINS HEALTH CARE LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
- 2 -
Financial risk management objectives and policies

The Group operates a number of risk management policies designed to minimise its exposure to financial risk.

 

Liquidity and cash flow risk                

The Group produces detailed management accounts and forecasts, which enable the directors to monitor the cash position and to ensure that ther is sufficient liquidity and cash flow to minimise the risk of the Group being able to pay its debts as they fall due.    

                    

Interest rate risk                

The Group utilises a number of financial instruments including bank loans and overdrafts in order to finance its operations. The primary risk faced by the Group as a result of its use of these financial instruments is interest rate risk.                

 

The bank overdraft borrowings at variable rates expose the Group to cash-flow interest risk, however the directors actively manage this risk by maintaining sufficient cash reserves within the Group to avoid using its overdraft facilities wherever possible.                

                

On behalf of the board

Mrs M E Jenkins
Director
17 December 2019
JENKINS HEALTH CARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2019
- 3 -

The directors present their annual report and financial statements for the year ended 31 March 2019.

Principal activities

The principal activity of the group was residential activities for the elderly and disabled.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr B J Jenkins
Mrs M E Jenkins
Mr T S Jenkins
Results and dividends

The results for the year are set out on page 8.

Dividends of £54,500 (2018: £Nil) were paid during the year.

 

Going concern

Notwithstanding net current liabilities of £550,481 (2018: £202,174), the directors have a reasonable expectation that the Group is well placed to manage their business risks and to continue in operational existence for the foreseeable future. Accordingly, the directors continue to adopt the going concern basis in preparing these financial statements.

Statement of directors' responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

JENKINS HEALTH CARE LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
- 4 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

On behalf of the board
Mrs M E Jenkins
Director
17 December 2019
JENKINS HEALTH CARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF JENKINS HEALTH CARE LIMITED
- 5 -
Opinion

We have audited the financial statements of Jenkins Health Care Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2019 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  • give a true and fair view of the state of the group's and the parent company's affairs as at 31 March 2019 and of the group's loss for the year then ended;

  • have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  • have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:

  • the directors' use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or

  • the directors have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the group's or the parent company’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

JENKINS HEALTH CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF JENKINS HEALTH CARE LIMITED
- 6 -

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

  • adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

  • the parent company financial statements are not in agreement with the accounting records and returns; or

  • certain disclosures of directors' remuneration specified by law are not made; or

  • we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: http://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

JENKINS HEALTH CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF JENKINS HEALTH CARE LIMITED
- 7 -

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Matthew Thomas (Senior Statutory Auditor)
for and on behalf of Baldwins Audit Services
18 December 2019
Statutory Auditor
Charter Court
Phoenix Way
Enterprise Park
SWANSEA
UK
SA7 9FS
JENKINS HEALTH CARE LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2019
- 8 -
2019
2018
Notes
£
£
Turnover
3
3,281,364
3,364,508
Cost of sales
(248,419)
(258,437)
Gross profit
3,032,945
3,106,071
Administrative expenses
(3,290,806)
(3,124,697)
Other operating income
8,522
-
Operating loss
4
(249,339)
(18,626)
Interest receivable and similar income
8,742
4,937
Interest payable and similar expenses
8
(74,609)
(79,348)
Loss before taxation
(315,206)
(93,037)
Tax on loss
9
15,706
(43,951)
Loss for the financial year
(299,500)
(136,988)
Other comprehensive income
Revaluation of tangible fixed assets
868,440
-
Tax relating to other comprehensive income
(116,000)
-
Total comprehensive income for the year
452,940
(136,988)
Loss for the financial year is all attributable to the owners of the parent company.
JENKINS HEALTH CARE LIMITED
GROUP BALANCE SHEET
AS AT
31 MARCH 2019
31 March 2019
- 9 -
2019
2018
Notes
£
£
£
£
Fixed assets
Goodwill
11
397,803
188,410
Tangible assets
12
6,100,836
4,485,145
6,498,639
4,673,555
Current assets
Stocks
16
8,500
8,500
Debtors
17
160,274
539,644
Cash at bank and in hand
238,979
79,144
407,753
627,288
Creditors: amounts falling due within one year
18
(958,234)
(829,462)
Net current liabilities
(550,481)
(202,174)
Total assets less current liabilities
5,948,158
4,471,381
Creditors: amounts falling due after more than one year
19
(3,248,300)
(2,285,963)
Provisions for liabilities
21
(454,500)
(338,500)
Net assets
2,245,358
1,846,918
Capital and reserves
Called up share capital
22
200
200
Revaluation reserve
2,189,573
1,452,987
Profit and loss reserves
55,585
393,731
Total equity
2,245,358
1,846,918
The financial statements were approved by the board of directors and authorised for issue on 17 December 2019 and are signed on its behalf by:
17 December 2019
Mrs M E Jenkins
Director
JENKINS HEALTH CARE LIMITED
COMPANY BALANCE SHEET
AS AT 31 MARCH 2019
31 March 2019
- 10 -
2019
2018
Notes
£
£
£
£
Fixed assets
Investments
13
1,788,854
1,788,854
Current assets
Debtors
17
103,869
55,869
Cash at bank and in hand
7,898
11,331
111,767
67,200
Creditors: amounts falling due within one year
18
(684,964)
(585,808)
Net current liabilities
(573,197)
(518,608)
Total assets less current liabilities
1,215,657
1,270,246
Creditors: amounts falling due after more than one year
19
(913,976)
(973,084)
Net assets
301,681
297,162
Capital and reserves
Called up share capital
22
200
200
Profit and loss reserves
301,481
296,962
Total equity
301,681
297,162

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £59,019 (2018 - £46,542 profit).

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 17 December 2019 and are signed on its behalf by:
17 December 2019
Mrs M E Jenkins
Director
Company Registration No. 06873327
JENKINS HEALTH CARE LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2019
- 11 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2017
100
1,486,074
497,632
1,983,806
Year ended 31 March 2018:
Loss and total comprehensive income for the year
-
-
(136,988)
(136,988)
Issue of share capital
22
100
-
-
100
Transfers of excess depreciation on revalued fixed assets
-
(33,087)
33,087
-
Balance at 31 March 2018
200
1,452,987
393,731
1,846,918
Year ended 31 March 2019:
Loss for the year
-
-
(299,500)
(299,500)
Other comprehensive income:
Revaluation of tangible fixed assets
-
868,440
-
868,440
Tax relating to other comprehensive income
-
(116,000)
-
(116,000)
Total comprehensive income for the year
-
752,440
(299,500)
452,940
Dividends
10
-
-
(54,500)
(54,500)
Transfers of excess depreciation on revalued fixed assets
-
(15,854)
15,854
-
Balance at 31 March 2019
200
2,189,573
55,585
2,245,358
JENKINS HEALTH CARE LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2019
- 12 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2017
100
250,420
250,520
Year ended 31 March 2018:
Profit and total comprehensive income for the year
-
46,542
46,542
Issue of share capital
22
100
-
100
Balance at 31 March 2018
200
296,962
297,162
Year ended 31 March 2019:
Profit and total comprehensive income for the year
-
59,019
59,019
Dividends
10
-
(54,500)
(54,500)
Balance at 31 March 2019
200
301,481
301,681
JENKINS HEALTH CARE LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2019
- 13 -
2019
2018
Notes
£
£
£
£
Cash flows from operating activities
Cash (absorbed by)/generated from operations
26
(74,511)
261,510
Interest paid
(74,609)
(79,348)
Income taxes refunded/(paid)
54,013
(96,187)
Net cash (outflow)/inflow from operating activities
(95,107)
85,975
Investing activities
Purchase of intangible assets
(335,000)
-
Purchase of tangible fixed assets
(857,454)
(2,201)
Proceeds from other investments and loans
334,990
(32,660)
Interest received
8,742
4,937
Net cash used in investing activities
(848,722)
(29,924)
Financing activities
Proceeds from issue of shares
-
100
Repayment of bank loans
1,099,955
(149,203)
Dividends paid to equity shareholders
(54,500)
-
Net cash generated from/(used in) financing activities
1,045,455
(149,103)
Net increase/(decrease) in cash and cash equivalents
101,626
(93,052)
Cash and cash equivalents at beginning of year
47,866
140,918
Cash and cash equivalents at end of year
149,492
47,866
Relating to:
Cash at bank and in hand
238,979
79,144
Bank overdrafts included in creditors payable within one year
(89,487)
(31,278)
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019
- 14 -
1
Accounting policies
Company information

Jenkins Health Care Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is Hollins Care Centre, The Hollins, Cimla, NEATH, UK, SA11 3BQ.

 

The group consists of Jenkins Health Care Limited and all of its subsidiaries.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

 

  • Section 4 ‘Statement of Financial Position’ – Reconciliation of the opening and closing number of shares;

  • Section 7 ‘Statement of Cash Flows’ – Presentation of a statement of cash flow and related notes and disclosures;

  • Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’ – Carrying amounts, interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

  • Section 33 ‘Related Party Disclosures’.

The consolidated financial statements incorporate those of Jenkins Health Care Limited and all of its subsidiaries (ie entities that the group controls through its power to govern the financial and operating policies so as to obtain economic benefits). Subsidiaries acquired during the year are consolidated using the merger method.

 

All financial statements are made up to 31 March 2019. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

 

 

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
1
Accounting policies (Continued)
- 15 -
1.2
Going concern

Financial forecasts and projections, taking into account reasonably possible changes in trading performance, show that the Group should be able to operate with its currently available facilities. As a consequence the directors have a reasonable expectation that the Group is well placed to manage their business risks and to continue in operational existence for the foreseeable future. Accordingly, the directors continue to adopt the going concern basis in preparing these financial statements.

1.3
Turnover

Turnover represents amounts receivable for care and nursing services provided during the year.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% straight line
Fixtures, fittings and equipment
15% reducing balance
Motor vehicles
25% reducing balance
1.5
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

 

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and net realisable value after making due provision for any slow moving or obsolete items.

1.7
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
1
Accounting policies (Continued)
- 16 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Goodwill

Determining whether goodwill is impaired requires an estimation of the value in use of the cash generating units to which goodwill has been allocated. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. The carrying amount of goodwill at the reporting end date is included in the relevant note to the accounts.

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
- 17 -
3
Turnover and other revenue
2019
2018
£
£
Turnover analysed by class of business
Residential care services
3,281,364
3,364,508
2019
2018
£
£
Other significant revenue
Interest income
8,742
4,937
4
Operating loss
2019
2018
£
£
Operating loss for the year is stated after charging:
Depreciation of owned tangible fixed assets
110,203
108,603
Amortisation of intangible assets
125,607
125,607
Cost of stocks recognised as an expense
248,419
258,437
Operating lease charges
10,935
4,472
5
Auditor's remuneration
2019
2018
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
1,000
1,000
Audit of the financial statements of the company's subsidiaries
4,000
4,000
5,000
5,000
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2019
2018
2019
2018
Number
Number
Number
Number
Administrative, care and support staff
124
127
-
-
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
6
Employees (Continued)
- 18 -

Their aggregate remuneration comprised:

Group
Company
2019
2018
2019
2018
£
£
£
£
Wages and salaries
2,511,846
2,294,094
-
-
Pension costs
17,555
7,247
-
-
2,529,401
2,301,341
-
-
7
Directors' remuneration
2019
2018
£
£
Remuneration for qualifying services
70,373
70,350
8
Interest payable and similar expenses
2019
2018
£
£
Interest on bank overdrafts and loans
74,609
79,348
9
Taxation
2019
2018
£
£
Current tax
UK corporation tax on profits for the current period
-
45,441
Adjustments in respect of prior periods
(15,706)
(1,490)
Total current tax
(15,706)
43,951
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
9
Taxation (Continued)
- 19 -

The actual (credit)/charge for the year can be reconciled to the expected credit for the year based on the profit or loss and the standard rate of tax as follows:

2019
2018
£
£
Loss before taxation
(315,206)
(93,037)
Expected tax credit based on the standard rate of corporation tax in the UK of 19.00% (2018: 19.00%)
(59,889)
(17,677)
Tax effect of expenses that are not deductible in determining taxable profit
914
870
Unutilised tax losses carried forward
10,019
30,668
Adjustments in respect of prior years
(15,706)
-
Amortisation and Depreciation add back
51,389
33,155
Capital allowances
(2,433)
(3,065)
Taxation (credit)/charge
(15,706)
43,951

In addition to the amount charged to the profit and loss account, the following amounts relating to tax have been recognised directly in other comprehensive income:

2019
2018
£
£
Deferred tax arising on:
Revaluation of property
116,000
-
10
Dividends
2019
2018
£
£
Interim paid
54,500
-
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
- 20 -
11
Intangible fixed assets
Group
Goodwill
£
Cost
At 1 April 2018
1,356,070
Additions - separately acquired
335,000
At 31 March 2019
1,691,070
Amortisation and impairment
At 1 April 2018
1,167,660
Amortisation charged for the year
125,607
At 31 March 2019
1,293,267
Carrying amount
At 31 March 2019
397,803
At 31 March 2018
188,410
The company had no intangible fixed assets at 31 March 2019 or 31 March 2018.
12
Tangible fixed assets
Group
Freehold land and buildings
Fixtures, fittings and equipment
Motor vehicles
Total
£
£
£
£
Cost or valuation
At 1 April 2018
4,650,000
959,064
19,949
5,629,013
Additions
856,914
540
-
857,454
Revaluation
668,086
-
-
668,086
At 31 March 2019
6,175,000
959,604
19,949
7,154,553
Depreciation and impairment
At 1 April 2018
213,322
910,598
19,948
1,143,868
Depreciation charged in the year
95,032
15,171
-
110,203
Revaluation
(200,354)
-
-
(200,354)
At 31 March 2019
108,000
925,769
19,948
1,053,717
Carrying amount
At 31 March 2019
6,067,000
33,835
1
6,100,836
At 31 March 2018
4,436,678
48,466
1
4,485,145
The company had no tangible fixed assets at 31 March 2019 or 31 March 2018.
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
12
Tangible fixed assets (Continued)
- 21 -

Certain freehold and leasehold land and buildings were valued on an open market basis by Pinders in 2017 and Sanderson Weatherall in 2019, both firms of independent Chartered Surveyors. The directors have considered the carrying value and do not consider it to be materially different to these valuations.

If revalued assets were stated on an historical cost basis rather than a fair value basis, the total amounts included would have been as follows:

Group
Company
2019
2018
2019
2018
£
£
£
£
Cost
3,847,258
2,990,344
-
-
Accumulated depreciation
(397,927)
(338,120)
-
-
Carrying value
3,449,331
2,652,224
-
-

 

13
Fixed asset investments
Group
Company
2019
2018
2019
2018
Notes
£
£
£
£
Investments in associates
-
-
1,788,854
1,788,854

 

Movements in fixed asset investments
Company
Shares in group undertakings and participating interests
£
Cost or valuation
At 1 April 2018 and 31 March 2019
1,788,854
Carrying amount
At 31 March 2019
1,788,854
At 31 March 2018
1,788,854
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
- 22 -
14
Subsidiaries

Details of the company's subsidiaries at 31 March 2019 are as follows:

Name of undertaking
Registered
Nature of business
Class of
% Held
office
shares held
Direct
Indirect
Cefn Lodge Limited
1
Residential care activities for the elderly and disabled.
Ordinary
100.00
Cherish Care Homes (Wales) Limited
1
Residential care activities for the elderly and disabled.
Ordinary
100.00
Saint Camillus Limited
1
Residential care activities for the elderly and disabled
Ordinary
100.00

1. Registered Office: Hollins Care Centre, The Hollins, Cimla, Neath, UK. SA11 3BQ.

 

Cefn Lodge Limited commenced trading 1 April 2019.

 

Under s479A of the Companies Act 2006, Cefn Lodge Limited (registered Number 10533770) is exempt from the requirements of the Act relating to the audit of individual accounts Jenkins Health Care Limited has guaranteed the liabilities of Cefn Lodge Limited.

15
Financial instruments
Group
Company
2019
2018
2019
2018
£
£
£
£
Carrying amount of financial assets
Debt instruments measured at amortised cost
160,274
539,644
n/a
n/a
Carrying amount of financial liabilities
Measured at amortised cost
4,005,961
2,993,173
n/a
n/a

As permitted by the reduced disclosure framework within FRS 102, the company has taken advantage of the exemption from disclosing the carrying amount of certain classes of financial instruments, denoted by 'n/a' above.

16
Stocks
Group
Company
2019
2018
2019
2018
£
£
£
£
Medication, food and consumables
8,500
8,500
-
-
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
- 23 -
17
Debtors
Group
Company
2019
2018
2019
2018
Amounts falling due within one year:
£
£
£
£
Trade debtors
69,115
71,467
-
-
Amounts owed by group undertakings
-
-
103,869
55,869
Other debtors
91,159
468,177
-
-
160,274
539,644
103,869
55,869
18
Creditors: amounts falling due within one year
Group
Company
2019
2018
2019
2018
Notes
£
£
£
£
Bank loans and overdrafts
20
444,019
248,192
48,000
47,665
Trade creditors
64,124
44,154
-
439
Amounts owed to group undertakings
-
91,159
-
-
Amounts owed to undertakings in which the group has a participating interest
-
57,812
-
-
Corporation tax payable
91,159
52,852
-
-
Other taxation and social security
109,414
69,400
-
-
Other creditors
207,920
226,094
636,964
537,704
Accruals and deferred income
41,598
39,799
-
-
958,234
829,462
684,964
585,808
19
Creditors: amounts falling due after more than one year
Group
Company
2019
2018
2019
2018
Notes
£
£
£
£
Bank loans and overdrafts
20
3,248,300
2,285,963
913,976
973,084
Amounts included above which fall due after five years are as follows:
Payable by instalments
1,664,683
1,403,359
721,976
767,476
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
- 24 -
20
Loans and overdrafts
Group
Company
2019
2018
2019
2018
£
£
£
£
Bank loans
3,602,832
2,502,877
961,976
1,020,749
Bank overdrafts
89,487
31,278
-
-
3,692,319
2,534,155
961,976
1,020,749
Payable within one year
444,019
248,192
48,000
47,665
Payable after one year
3,248,300
2,285,963
913,976
973,084

The long-term loans are secured by fixed and floating charges over all property and assets of the Group.

Interest is charged on bank loans at variable rates and are repayable in more than 5 years by regular monthly repayments.

21
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:

Liabilities
Liabilities
2019
2018
Group
£
£
Accelerated capital allowances
6,500
6,500
Revaluations
448,000
332,000
454,500
338,500
The company has no deferred tax assets or liabilities.
Group
Company
2019
2019
Movements in the year:
£
£
Liability at 1 April 2018
338,500
-
Charge to other comprehensive income
116,000
-
Liability at 31 March 2019
454,500
-

 

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
- 25 -
22
Share capital
Group and company
2019
2018
Ordinary share capital
£
£
Issued and fully paid
152 Ordinary A of £1 each
152
152
24 Ordinary B of £1 each
24
24
12 Ordinary C of £1 each
12
12
12 Ordinary D of £1 each
12
12
200
200

 

23
Operating lease commitments
Lessee

Operating lease payments represent rentals payable by the company for certain items of equipment and use of motor pool vehicles. Leases are negotiated on average for term of 3 years and rentals are fixed for the duration of the lease.

24
Related party transactions
Transactions with related parties

During the year the group provided services and recharged certain cost to Cefn Lodge Partnership, a business under the control of the directors, as follows:

2019
2018
£
£
Group
Cefn Lodge Partnership
63,522
10,678

The following amounts were outstanding at the reporting end date:

Amounts due to related parties
2019
2018
£
£
Group
Cefn Lodge Partnership
-
57,812
Company
Cefn Lodge Partnership
-
116,599
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
24
Related party transactions (Continued)
- 26 -

The following amounts were outstanding at the reporting end date:

Amounts due from related parties
2019
2018
Balance
Balance
£
£
Group
Director - Mr B Jenkins
2,938
334,990

The Group charged interest on outstanding directors loans during the period of £8,741 (2018: £4,937).

 

At the 31 March 2019, wholly owned subsidiary Cefn Lodge Limited, acquired the nursing home previously operated by Cefn Lodge Partnership, a business controlled by the directors. Goodwill was paid to the directors on acquisition of £335,000.

25
Controlling party

The company is controlled by the director Mrs M Jenkins who owns the majority of share capital.

26
Cash (absorbed by)/generated from group operations
2019
2018
£
£
Loss for the year after tax
(299,501)
(136,988)
Adjustments for:
Taxation (credited)/charged
(15,706)
43,951
Finance costs
74,609
79,348
Investment income
(8,742)
(4,937)
Amortisation and impairment of intangible assets
125,607
125,607
Depreciation and impairment of tangible fixed assets
110,203
108,603
Movements in working capital:
Decrease in stocks
-
1,277
Decrease/(increase) in debtors
44,380
(59,936)
(Decrease)/increase in creditors
(105,361)
104,585
Cash (absorbed by)/generated from operations
(74,511)
261,510
2019-03-312018-04-01falseCCH SoftwareCCH Accounts Production 2019.301Mr B J JenkinsMrs M E JenkinsMr T S Jenkins068733272018-04-012019-03-3106873327bus:Director12018-04-012019-03-3106873327bus:Director22018-04-012019-03-3106873327bus:Director32018-04-012019-03-3106873327bus:RegisteredOffice2018-04-012019-03-3106873327bus:Consolidated2018-04-012019-03-3106873327bus:Consolidated2019-03-31068733272019-03-31068733272018-03-3106873327core:ShareCapital2019-03-3106873327core:ShareCapital2018-03-31068733272017-04-012018-03-3106873327core:ShareCapital2017-04-012018-03-3106873327core:LandBuildingscore:OwnedOrFreeholdAssets2018-04-012019-03-3106873327core:FurnitureFittings2018-04-012019-03-3106873327core:MotorVehicles2018-04-012019-03-3106873327core:Subsidiary12018-04-012019-03-3106873327core:Subsidiary22018-04-012019-03-3106873327core:Subsidiary32018-04-012019-03-3106873327core:Subsidiary112018-04-012019-03-3106873327core:Subsidiary212018-04-012019-03-3106873327core:Subsidiary312018-04-012019-03-3106873327core:Subsidiary122018-04-012019-03-3106873327core:Subsidiary222018-04-012019-03-3106873327core:Subsidiary322018-04-012019-03-3106873327core:CurrentFinancialInstruments2019-03-3106873327core:CurrentFinancialInstruments2018-03-3106873327core:Non-currentFinancialInstruments2019-03-3106873327core:Non-currentFinancialInstruments2018-03-3106873327bus:PrivateLimitedCompanyLtd2018-04-012019-03-3106873327bus:FRS1022018-04-012019-03-3106873327bus:Audited2018-04-012019-03-3106873327bus:ConsolidatedGroupCompanyAccounts2018-04-012019-03-3106873327bus:FullAccounts2018-04-012019-03-31xbrli:purexbrli:sharesiso4217:GBP